Trials / Terminated
TerminatedNCT02312479
Safety and Performance Study of the Nyxoah SAT System for Treating OSA
Safety and Performance Study of the Use of the Nyxoah SAT System for the Treatment of Obstructive Sleep Apnea
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Nyxoah S.A. · Industry
- Sex
- All
- Age
- 21 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
A prospective open-label, single treatment study to assess the safety and the performance of the Nyxoah SAT system for the treatment of Obstructive Sleep Apnea
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Nyxoah SAT system | The Nyxoah SAT system is comprised of an implantable nerve stimulator implanted over one of the tongue muscles via a minimally invasive procedure. Stimulation of the Hypoglossal nerves causes the tongue muscles to contract, thus maintaining an open airway during sleep. |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2015-11-01
- Completion
- 2016-04-01
- First posted
- 2014-12-09
- Last updated
- 2016-09-27
Locations
2 sites across 2 countries: Belgium, Germany
Source: ClinicalTrials.gov record NCT02312479. Inclusion in this directory is not an endorsement.